BASDAI CHANGES IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR THERAPY

被引：0
|
作者：
Clarke, Laura [1 ,2 ]
Kay, Lesley [1 ,2 ]
机构：
[1] Newcastle Hosp NHS Fdn Trust, Musculoskeletal Unit, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England
来源：
RHEUMATOLOGY | 2010年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I58 / I59
页数：2
相关论文
共 50 条
  • [41] Is the Basdai Score Driven By Pain in Ankylosing Spondylitis Patients Treated with Anti-TNF?
    Rahman, Proton
    Jovaisas, Algis
    Bensen, William
    Olszynski, Wojciech
    Jaroszynska, Anna
    Baer, Philip
    Sheriff, Maqbool
    Sholter, Dalton
    Psaradellis, Eliofotisti
    Sampalis, John S.
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan
    Shawi, May
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S103 - S104
  • [42] IS THE BASDAI SCORE DRIVEN BY PAIN IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH ANTI-TNF?
    Rahman, P.
    Jovaisas, A.
    Bensen, W.
    Olszynski, W.
    Jaroszynska, A.
    Baer, P.
    Sheriff, M.
    Sholter, D.
    Psaradellis, E.
    Sampalis, J. S.
    Nantel, F.
    Otawa, S.
    Lehman, A. J.
    Tkaczyk, C.
    Shawi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 266 - 266
  • [43] ASSESSMENT OF SALARY GROWTH IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH AND WITHOUT ANTI-TUMOR NECROSIS FACTOR THERAPY
    Deodhar, A.
    Mittal, M.
    Joshi, A.
    Signorovitch, J. E.
    Yang, M.
    Bao, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 744 - 744
  • [44] How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?
    Sieper, J
    Rudwaleit, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 61 - 64
  • [45] Drug concentrations and prevalence of anti-drug antibodies in ankylosing spondylitis patients using self-injected anti-tumour necrosis factor drugs
    Parmanne, P.
    Sokka-Isler, T.
    Lamberg, T.
    Isomaki, P.
    Kaipiainen-Seppanen, O.
    Uutela, T.
    Pirila, L.
    Kauppi, M.
    Yli-Kerttula, T.
    Tuompo, R.
    Relas, H.
    Ekman, P.
    Santisteban, A.
    Kokko, A.
    Tadesse, K.
    Leirisalo-Repo, M.
    Romu, M.
    Valleala, H.
    Borodina, J.
    Elfving, P.
    Peltomaa, R.
    Kautiainen, H.
    Jokiranta, T. S.
    Eklund, K. K.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (05) : 436 - 436
  • [46] Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
    Rosner, I.
    Haddad, A.
    Boulman, N.
    Feld, J.
    Avshovich, N.
    Slobodin, G.
    Rozenbaum, M.
    RHEUMATOLOGY, 2007, 46 (09) : 1508 - 1508
  • [47] Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Madhok, Rajan
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1571 - 1571
  • [48] Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
    Roux, C. H.
    Brocq, O.
    Breuil, V.
    Albert, C.
    Euller-Ziegler, L.
    RHEUMATOLOGY, 2007, 46 (04) : 695 - 698
  • [49] Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis
    Moura, C. S.
    Rahme, E.
    Maksymowych, W. P.
    Abrahamowicz, M.
    Bessette, L.
    Bernatsky, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2019, 48 (02) : 121 - 127
  • [50] Anti-tumour necrosis factor a therapy: can we afford it?
    Symmons, DPM
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 969 - 970
12345